Clinical Trials Directory

Trials / Completed

CompletedNCT00849264

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

a Randomized Controlled Study of Surgical Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Eastern Hepatobiliary Surgery Hospital · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study is working to evaluate the surgical comprehensive treatment for different types of tumor thrombi in the portal vein for hepatocellular carcinoma patients, to establish a standardized, unified, effective therapeutic program.

Detailed description

Primary liver cancer (PLC) has a great tendency to invade portal vein intravascularly, results in the formation of portal vein tumor thrombus (PVTT), which is a crucial factor that can worsen the prognosis of patients with PLC. In clinical, various treatments have been applied to improve this short-term prognosis, but there was no identical indication for treatment of PLC patients with different PVTT. The objective of this study is to evaluate the surgical comprehensive treatment for different types of tumor thrombi in the portal vein for hepatocellular carcinoma patients, to establish a standardized, unified, effective therapeutic program.

Conditions

Interventions

TypeNameDescription
DRUGchemotherapy with endostar15mg/d×14d
DRUGtreatment with CBP and 5-FUCBP 300mg/d×2d,5-FU 1000mg/d×5d
DRUGtreatment with endostar, CBP and 5-FUCBP 300mg/d×2d,5-FU 1000mg/d×5d ,Endostar 15mg/d×14d

Timeline

Start date
2008-12-01
Primary completion
2009-12-01
Completion
2010-12-01
First posted
2009-02-23
Last updated
2016-04-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00849264. Inclusion in this directory is not an endorsement.